Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vietnam malaria therapeutic efficacy surveillance study
ACTRN12611000181909Phase 4Completed
- Sponsor
- Ministry of Health
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of artesunate, dihydroartemisinin + piperaquine and chloroquine in malaria, Falciparum malaria (PF) and vivax malaria, sponsored by Ministry of Health. Primary endpoint: 28-day cure rate or adequate clinical and parasitological response. Started Sep 2008; status: completed.
02
Drugs
artesunatedihydroartemisinin + piperaquinechloroquine
03
Conditions
malariaFalciparum malaria (PF)vivax malaria
Beyond the preview
Go deeper on ACTRN12611000181909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000181909.